The factor structure of depressive symptoms in patients with obesity enrolled in the RAINBOW clinical trial.
The factor structure of depressive symptoms in patients with obesity enrolled in the RAINBOW clinical trial.
复制标题
参加 RAINBOW 临床试验的肥胖患者抑郁症状的因素结构。
DOI：
10.1016/j.jad.2020.11.105
复制
发表时间：
2021-02-15
影响因子：
6.6
通讯作者：
Ma J
中科院分区：
文献类型：
--
作者：
Majd M;Smyth JM;Lv N;Xiao L;Snowden MB;Venditti EM;Williams LM;Ajilore OA;Suppes T;Ma J
Examining variability in the presenting symptoms of depression may be particularly important in characterizing depression in patients with comorbid conditions such as obesity. Identifying the underlying constructs of depression in such patients may produce phenotypic information to aid diagnosis and treatment decisions. To examine the latent factors of symptoms using the depression Symptom Checklist (SCL-20) and the Patient Health Questionnaire (PHQ-9), separately, in patients with obesity and elevated depressive symptoms. Exploratory factor analysis (EFA) was performed on baseline data from 409 patients with obesity and elevated depressive symptoms recruited in primary care. Bootstrap analysis was performed to estimate the precision and potential replicability of identified latent factors. Participants (70% women, mean age of 51.0 ± 12.1 years) had moderate depression. EFA of the SCL-20 suggested two reliable factors: dysphoric mood (71% of the variance) and anhedonia (15% of the variance). EFA of the PHQ-9 yielded one factor: dysphoric mood (87% of the variance). Bootstrapped results supported the replicability of these results. The top most endorsed symptoms were feeling low energy, overeating and disturbed sleep. The generalizability of these findings to severe depression may be limited. Patients with elevated depressive symptoms and obesity present with heterogeneous symptoms. The SCL-20 seems more sensitive than the PHQ-9 for differentiating symptom profiles in this population. Some possible reasons include: 1) differences in number of scale items, and 2) differences in the aspects of depression they tap into; the SCL-20 measures the severity of symptoms, whereas the PHQ-9 measures the frequency of symptoms.
登录
查看更多内容
影响因子：
4.8
作者：
Cooper CB;Neufeld EV;Dolezal BA;Martin JL
通讯作者：
Martin JL
影响因子：
7.4
作者：
Felger JC;Miller AH
通讯作者：
Miller AH
影响因子：
3.4
作者：
Hargens TA;Kaleth AS;Edwards ES;Butner KL
通讯作者：
Butner KL
影响因子：
3.6
作者：
Goss, Kenneth;Allan, Steven
通讯作者：
Allan, Steven
影响因子：
10.6
作者：
Dowlati, Yekta;Herrmann, Nathan;Lanctot, Krista L.
通讯作者：
Lanctot, Krista L.